{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T02:45:10Z","timestamp":1773197110132,"version":"3.50.1"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:p>This cohort study compares outcomes for patients with hematologic malignant tumors who prophylactically received tixagevimab-cilgavimab against SARS-CoV-2 with those who did not.<\/jats:p>","DOI":"10.1001\/jamaoncol.2023.6446","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T16:34:07Z","timestamp":1706200447000},"page":"405","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of Tixagevimab-Cilgavimab as Immunoprophylaxis in Patients With Hematologic Cancer"],"prefix":"10.1001","volume":"10","author":[{"given":"Marco","family":"Salvini","sequence":"first","affiliation":[{"name":"ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo Antonio","family":"Grossi","sequence":"additional","affiliation":[{"name":"ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy"},{"name":"Department of Medicine and Surgery, University of Insubria, Varese, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Cacioppo","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Insubria, Varese, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Merli","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Milano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Pellegrini","sequence":"additional","affiliation":[{"name":"ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Brociner","sequence":"additional","affiliation":[{"name":"ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Passamonti","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Milano, Italy"},{"name":"Department of Medicine and Surgery, Universit\u00e0 degli Studi di Milano, Milano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"8","key":"cld230024r1","doi-asserted-by":"publisher","first-page":"E321","DOI":"10.1002\/ajh.v97.8","article-title":"Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: results of a prospective cohort study of 365 patients.","volume":"97","author":"Salvini","year":"2022","journal-title":"Am J Hematol"},{"issue":"23","key":"cld230024r2","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1056\/NEJMoa2116620","article-title":"Intramuscular AZD7442 (tixagevimab-cilgavimab) for prevention of COVID-19.","volume":"386","author":"Levin","year":"2022","journal-title":"N Engl J Med"},{"issue":"6","key":"cld230024r3","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ccell.2022.05.007","article-title":"Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies.","volume":"40","author":"Stuver","year":"2022","journal-title":"Cancer Cell"},{"issue":"2","key":"cld230024r4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1182\/blood.2022018283","article-title":"Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies.","volume":"141","author":"Davis","year":"2023","journal-title":"Blood"},{"issue":"1","key":"cld230024r5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13045-023-01423-7","article-title":"Passive pre-exposure immunization by tixagevimab\/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry.","volume":"16","author":"Marchesi","year":"2023","journal-title":"J Hematol Oncol"},{"key":"cld230024r6","unstructured":"Istituto Superiore di Sanit\u00e0. EpiCentro - Epidemiology for public health. Accessed February 7, 2023. https:\/\/www.epicentro.iss.it\/"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2814260\/jamaoncology_salvini_2024_ld_230024_1710962825.34162.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T15:03:38Z","timestamp":1711033418000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2814260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2023.6446","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}